Enzymes: Protease 375K
Advanced Enzyme Formula
Price: $28.00
Quantity: 60 capsules
Price: $54.00
Quantity: 120 capsules
Ingredients: TzymeTM Protease Blend (360,000
HUT), acid, neutral, alkaline, exo/endo peptidases, bromelain
and papain (600,000 PU) and Calcium citrate (9.60 mg)
Description**
TPPTM Protease is a proprietary blend of
highly active proteolytic enzymes with a wide range of pH
stability. Proteolytic enzymes taken orally under certain
conditions have been shown to be absorbed in substantial
quantities into the blood.1,2,3 Once in the blood circulation,
the enzymes in this blend bind to serum proteins, particularly
alpha 2-macroglobulin (a2M), and impart immunomodulatory
benefits.4 One of the best-established functions served
by the oral proteases in Tzyme blend is in the maintenance
of normal blood flow. This is accomplished by breaking down
blood clots (fibrinolysis) and platelet aggregation within
blood vessels and breaking down excess extra-vascular plasma
proteins as in edema. TPPTM Protease will also enhance the
hydrolysis of food proteins for enhanced bio-availability
of amino acids.
Modulation of the Immune System: As a
result of their coupling to 2M, TzymeTM proteolytic enzymes
exhibit an increased binding of several very important cytokines
(hormones-like molecules which have a powerful influence
on immune cells) such as Transforming growth factor-beta
(TGP-B), and Tumor Necrosis Factor-alpha (TNF-a).5 Studies
have indicated that oral hydrolytic enzymes affect cytokine
synthesis and modulatory effects.6 For instance, TNF-a synthesis,
which is a necessary step in host defense against tumor
cells,7 is impaired when experimentally inactivated oral
proteolytic enzymes were used.8
Thus, active, GI stable and functional oral enzymes that
are absorbed in the blood stream can provide therapeutic
applications. In addition, studies have shown that oral
proteolytic enzymes increased the tumoricidal and cytotoxic
activities of polymorphonuclear neutrophils.9
Bromelain, an important addition to the TzymeTM Protease
Blend, is a protease derived from the pineapple plant. It
has been used for many years as a digestive aid, anti-inflammatory
and burn debridement agent. Its actions help to prevent
swelling/edema, promote smooth muscle relaxation, inhibit
platelet aggregation, and enhance antibiotic absorption.
Bromelain is also used in cancer treatment, ulcer prevention,
sinusitis relief, appetite inhibition and shortening of
labor.10,11 Proteolytic enzymes administered orally improved
the survival time, the hematological parameters of spontaneous
lymphoblastic leukemia in rats, and the metastasis and survival
time of mice with Lewis lung carcinoma.12
Several hypotheses have been put forth as to the mechanisms
by which proteolytic enzymes modulate the immune system
to control and eliminate tumors. Some studies indicated
that proteolytic enzymes selectively remove some adhesion
molecules such as CD4, CD44, B7-1, ICAM-1, B7-2, CD45RA,
CD6, CD7, E2/MIC2, and Leu81/LAM 1 from cell surfaces.13,14,15,16
According to Hale et al.16 the removal of these surface
molecules has markedly enhanced CD2 mediated T-cell activity.
Some studies have implied that by removing the glycoprotein
CD44, some proteases help control the tumor growth of certain
types of cells. This selective removal of some mediator
proteins, and the regulation of cytokines19,8,6,5 constitute
some factors by which proteolytic enzymes are thought to
modulate the immune system and act as biological response
modifiers.
Indications:
Impaired Kidney Function - Glomerulonephritis:
In this disease there is a build up of protein in the basement
membrane of the glomeruli of the kidneys. Fluids must pass
through this basement membrane in the initial phase of the
filtration of the blood by the kidneys. Recent research
using an animal model of this disease "lends further
support to the concept that enzymes capable of degrading
immune complexes in situ can ameliorate glomerulonephritis".17
Heavy Metal Toxins - Heavy metals such
as lead (Pb) and mercury (Hg) exert their poisoning effect
by binding to ionizable or sulfhydryl groups of proteins,
including vital enzymes. Once these metals bind to an essential
functional protein, such as an enzyme, they denature and/or
inhibit it. This interaction of heavy metals to proteins
can lead to degenerating diseases, nerve damage or even
death.
When taken on an empty stomach, it should be noted that
protease is readily taken up into the mucosa cells of the
intestine and passed into blood circulation. Clinical observations
have noted that upon high intake of TPPTM Protease, heavy
metal concentrations have been significantly decreased in
the blood.
Recommended Dosages:
Take one (1) capsule two times daily on an empty stomach
with 8 oz. of water. If you have difficulty swallowing capsules
remove contents from capsule, mix with a small amount of
tepid water and ingest immediately.
Dosage may be increased according to need and/or as indicated
by your health care professional.
References:
-
M.L.G. Gardner and K.-J. Steffens.
Absorption of Orally Administered Enzymes eds. Berlin,
Germany: Springer-Verlag, 1995.
-
Castell J.V., Friedrich G., Kuhn C.-S.
& Poppe G.E., "Intestinal absorption of undegraded
proteins in men: presence of bromelain in plasma after
oral intake", Am J Physiol 1997; 273:G139-G146.
-
Larsson L.J.; Frisch E.P.; Torneke
K.; Lindblom T. & Bjork I., "Properties of the
complex between alpha 2-macroglobulin and brinase, a proteinase
from Aspergillus oryzae with thrombolytic effect",
Thromb Res 1988; 49:55-68.
-
Nouza K., "Outlooks of systemic
enzyme therapy in rheumatoid arthritis and other immunopathological
disease", Acta Univ Caroll [Med] 1994; 40:101-4.
-
LaMarre J., Wollenberg G.K., Gonias
S.L. & Hayes M.A., "Biology of Disease: Cytokine
binding and dearance properties of proteinase-activeated
a2 -macroglobulins", Lab lnv 1991; 65:3-14.
-
Desser L., Rehberger A., et al. 1993:
Int. J. of Cancer Res. And Treatment, 50:403.
-
Arai K., Lee F., et al., 1990: Ann.
Rev., Biochem, 59:783.
-
Desser L., Rehberger A., and Paukovits
W., 1994: Cancer Biotherapy, 9:253.
-
Zavadova E., Desser L., et al., 1995:
Cancer Biotherapy, 10:147.
-
Taussig S.J., and Batkin S., et al.,
1988: J. Ethnopharmacol, 22:191.
-
Gerard G., 1972: Agressology, 13:261.
-
Wald M., Zavadova E., et al., 1998:
Life Sciences (Pharmacology Letters), 62:43.
-
Kiessling L.L., and Gordon E.J., 1998:
Chemistry and Biology, 5:R49.
-
Targoni O.S., Tary-Lehmann M., and
Lehmann P.V., 1999: Journal of Autoimmunity, 12:191.
-
Harrach T., Gebauer F., et al., 1994:
International Journal of Oncology, 5:485.
-
Hale L.P., Haynes B.F., 1992: J. Immunol.,
149:3809.
-
Gesualdo l., Ricanati S., Hassa M.O.,
Emancipator S.N., & Lamm M.E., "Enzymolysis of
glomerular immune deposits in vivo with dextranase/protease
ameliorates proteinuria, hematuria, and mesangial proliferation
in murine experimental IgA nephropathy", J. Clin
Invest 1990; 86:715-722.
** Disclaimer: All information presented by Natural Healing
House is for educational purposes only. The articles are
not intended to substitute for a consultation with your
physician. In case of medical questions or uncertainties,
the reader is encouraged to seek the advice of his/her own
physician or health care practitioner. The products listed
have not been evaluated by the FDA and, therefore, cannot
claim to treat, diagnose, cure or prevent any disease.
|